Page last updated: 2024-12-06

epsilon-dinitrophenyllysine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

epsilon-dinitrophenyllysine: RN given refers to (L-Lys)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

N(6)-(2,4-dinitrophenyl)-L-lysine : The L-stereoisomer of N(6)-(2,4-dinitrophenyl)lysine, a lysine derivative having a 2,4-dinitrophenyl substituent at the N(6)-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID65068
CHEMBL ID2028905
CHEBI ID53080
SCHEMBL ID295431
MeSH IDM0050730

Synonyms (26)

Synonym
epsilon-n-(2,4-dinitrophenyl)-l-lysine
epsilon-dinitrophenyllysine
epsilon-dnp-lysine
dinitrophenyl-lysine
epsilon-2,4-dinitrophenol lysine
(2s)-2-amino-6-(2,4-dinitroanilino)hexanoic acid
dnp-l-lys
1094-76-4
n(6)-(2,4-dinitrophenyl)-l-lysine
CHEBI:53080 ,
l-lysine, n6-(2,4-dinitrophenyl)-
s6td66f98c ,
unii-s6td66f98c
EPITOPE ID:114088
CHEMBL2028905
SCHEMBL295431
n~6~-(2,4-dinitrophenyl)lysinato
DTXSID10911153
h-lys(dnp)-oh
OFKKPUNNTZKBSR-VIFPVBQESA-N
lys(dnp)
Q27123949
n6-(2,4-dinitrophenyl)-l-lysine
dnp-l-lysine
.epsilon.-dnp-l-lysine
AKOS040751707
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
N(6)-(2,4-dinitrophenyl)lysineA lysine derivative having a 2,4-dinitrophenyl substituent at the N(6)-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID127482Ability to bind to monoclonal antibody IgE (Lb4), expressed as association constant (LogKA)1996Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
Comparative molecular field analysis of haptens docked to the multispecific antibody IgE(Lb4)
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (38.71)18.7374
1990's15 (48.39)18.2507
2000's3 (9.68)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]